Delivering therapeutic innovation, applications and technologies in NGS, Single Cell Analysis and Genome Editing
Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from critical discussions in the future of Next Generation Sequencing, Multi-omic Single Cell Analysis (including Spatial Transcriptomics) and Genome editing in Drug Discovery and Therapeutic Development
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Harvard Medical School
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.